ACA
SNY icon

Atlas Capital Advisors’s Sanofi SNY Stock Holding History

Atlas Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8K Sell
89
-2,488
-97% -$111K ﹤0.01% 943
2026
Q1 		$124K Hold
2,577
– – 0.01% 493
2025
Q4 		$125K Buy
+2,577
New +$128K 0.01% 500
2025
Q2 		$85.5K Hold
1,769
– – 0.01% 554
2025
Q1 		$98.1K Hold
1,769
– – 0.01% 549
2024
Q4 		$85.3K Hold
1,769
– – 0.01% 542
2024
Q3 		$102K Hold
1,769
– – 0.02% 493
2024
Q2 		$85.8K Hold
1,769
– – 0.01% 522
2024
Q1 		$86K Sell
1,769
-537
-23% -$26.2K 0.01% 498
2023
Q4 		$115K Sell
2,306
-206
-8% -$10.1K 0.02% 472
2023
Q3 		$135K Hold
2,512
– – 0.02% 405
2023
Q2 		$135K Sell
2,512
-440
-15% -$23.7K 0.02% 429
2023
Q1 		$161K Buy
2,952
+440
+18% +$21.4K 0.03% 397
2022
Q4 		$122K Buy
2,512
+1,247
+99% +$54.7K 0.02% 421
2022
Q3 		$48.1K Sell
1,265
-4,607
-78% -$205K 0.01% 539
2022
Q2 		$294K Hold
5,872
– – 0.05% 285
2022
Q1 		$301K Buy
5,872
+325
+6% +$16.8K 0.05% 288
2021
Q4 		$278K Buy
5,547
+3,305
+147% +$163K 0.04% 308
2021
Q3 		$108K Sell
2,242
-1,354
-38% -$68.8K 0.02% 424
2021
Q2 		$189K Sell
3,596
-798
-18% -$41.6K 0.03% 366
2021
Q1 		$217K Sell
4,394
-4,336
-50% -$208K 0.04% 317
2020
Q4 		$424K Sell
8,730
-1,832
-17% -$90.4K 0.09% 202
2020
Q3 		$530K Buy
+10,562
New +$544K 0.13% 174
2019
Q3 		– Sell
-3,797
Closed -$164K – 693
2019
Q2 		$164K Buy
+3,797
New +$161K 0.05% 322
2018
Q2 		– Sell
-20,296
Closed -$813K – 557
2018
Q1 		$813K Buy
+20,296
New +$845K 0.25% 117

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Atlas Capital Advisors's SNY Position: Q2 2026 in Review

Atlas Capital Advisors reduced its Sanofi (SNY) stake by 97% in Q2 2026, selling an estimated $111K and leaving 89 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

Atlas Capital Advisors first reported a position in SNY in Q1 2018 and has held it in 25 quarters since. The position peaked at $813K in Q1 2018. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Atlas Capital Advisors held 89 shares of Sanofi worth $3.8K as of Q2 2026.
  • Atlas Capital Advisors sold 2,488 Sanofi shares in Q2 2026, an estimated $111K.
  • Sanofi made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2026, its #943 holding.
  • Atlas Capital Advisors first reported a position in Sanofi in Q1 2018 and has held it in 25 quarters since.
  • Atlas Capital Advisors's Sanofi position peaked at $813K in Q1 2018.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.